BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Sp600125

pyrazolanthrone [Supplementary Concept] JNK (c-Jun N-terminal kinase) inhibitor; structure in first source

117+ PubMed studies analyzed · Evidence Score: 39

Research Domains

Sp600125 has been studied across 18 research domains including 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity, 🫁 Liver & Detox, 🧘 Stress & Anxiety. The primary research focus is 🔬 Oncology with 45% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sp600125, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

su
94 shared targets
midostaurin
86 shared targets
kw
96 shared targets
ast
78 shared targets
lestaurtinib
103 shared targets
tae
90 shared targets
nintedanib
75 shared targets
sp
38 shared targets
r
82 shared targets
alsterpaullone
46 shared targets
Loading evidence profile...

This evidence profile for Sp600125 is generated deterministically from 117 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.